
An initial investigation by the CMA into an acquisition of dental practices has found competition concerns in parts of Doncaster, Yorkshire and Alfreton, Derbyshire.
The Competition and Markets Authority (CMA) carried out a Phase 1 investigation into the completed purchase of Dental Partners Group Limited (Dental Partners) by Riviera Bidco Limited (Riviera) – owner of existing dental practice operator Rodericks Dental Limited (Rodericks).
The investigation looked at the potential impact of the merger in the areas where both businesses currently offer NHS or private dental treatments. While sufficient competition will remain after the merger in most cases, the CMA found that the merger would raise competition concerns in the provision of general NHS dental treatments, such as check-ups and fillings, in areas within Doncaster and Alfreton.
The removal of Dental Partners as an independent competitor could lead to reduced choice for patients in these two areas, where the availability of NHS dental appointments is already limited.
Prior to the conclusion of the investigation, the businesses accepted that the merger would raise concerns in these 2 areas and asked the CMA to move straight to a discussion of potential remedies to address these concerns.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas